Streamline Cash Conversion Cycle from 2010 to 2024

STRM Stock  USD 2.31  0.02  0.87%   
Streamline Health Cash Conversion Cycle yearly trend continues to be very stable with very little volatility. Cash Conversion Cycle is likely to grow to 61.74 this year. During the period from 2010 to 2024, Streamline Health Cash Conversion Cycle quarterly data regression pattern had sample variance of  2,203 and median of  73.74. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
39.66365939
Current Value
61.74
Quarterly Volatility
46.93974656
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Streamline Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Streamline Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 M, Total Revenue of 19.1 M or Gross Profit of 9.9 M, as well as many indicators such as Price To Sales Ratio of 0.93, Dividend Yield of 0.0 or PTB Ratio of 1.11. Streamline financial statements analysis is a perfect complement when working with Streamline Health Valuation or Volatility modules.
  
Check out the analysis of Streamline Health Correlation against competitors.

Latest Streamline Health's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Streamline Health Solutions over the last few years. It is Streamline Health's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Streamline Health's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Pretty Stable
   Cash Conversion Cycle   
       Timeline  

Streamline Cash Conversion Cycle Regression Statistics

Arithmetic Mean84.58
Geometric Mean71.37
Coefficient Of Variation55.49
Mean Deviation36.42
Median73.74
Standard Deviation46.94
Sample Variance2,203
Range162
R-Value(0.20)
Mean Square Error2,276
R-Squared0.04
Significance0.47
Slope(2.12)
Total Sum of Squares30,847

Streamline Cash Conversion Cycle History

2024 61.74
2023 39.66
2022 110.22
2021 64.89
2020 171.36
2019 12.71
2018 51.48

About Streamline Health Financial Statements

Streamline Health investors utilize fundamental indicators, such as Cash Conversion Cycle, to predict how Streamline Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Conversion Cycle 39.66  61.74 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:
Check out the analysis of Streamline Health Correlation against competitors.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
12.131
Earnings Share
(4.62)
Revenue Per Share
5.249
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.11)
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.